Vetoryl

Verify with FDA CVM →

78 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
78
Total Reports
12
Deaths Reported
1540.0%
Death Rate

Active Ingredients

Vetoryl

Administration Routes

UnknownOralSubcutaneous

Species Affected

Dog 78

Most Affected Breeds

Retriever - Labrador 6
Terrier (unspecified) 5
Chihuahua 5
Shih Tzu 4
Boxer (German Boxer) 4
Retriever - Golden 4
Terrier - West Highland White 4
Crossbred Canine/dog 4
Terrier - Fox Wire 3
Maltese 3

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 13
Diarrhoea 9
Vomiting 8
Weakness 7
Death by euthanasia 7
Partial lack of efficacy 7
Unable to walk 6
Ataxia 6
Proprioception deficit 5
Knuckling 5
Death 5
Polydipsia 5

Outcome Breakdown

Ongoing
42 (53.8%)
Outcome Unknown
15 (19.2%)
Recovered/Normal
9 (11.5%)
Euthanized
7 (9.0%)
Died
5 (6.4%)

Data Summary

Metric Value
Total adverse event reports 78
Reports involving death 12
Case-fatality rate (reported events) 1540.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Vetoryl Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 78 adverse event reports referencing Vetoryl, including 12 reports in which the animal died — a 1540.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Vetoryl. Reported administration routes include Unknown, Oral, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Vetoryl reports are Dog (78 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (6), Terrier (unspecified) (5), Chihuahua (5) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Vetoryl are Lethargy (see also Central nervous system depression in Neurological) (13), Diarrhoea (9), Vomiting (8), Weakness (7). Of the 78 reports with a coded outcome, Ongoing is the leading category at 53.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Vetoryl.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial